Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents.

Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents.

BACKGROUND: Serotonin (5HT), a naturally occurring vasoactive substance, is released from platelets into plasma under various pathological conditions. Recently, anticancer drugs that act by selectively disrupting tumour blood flow have been found to increase plasma 5HT concentrations in mice. Two su...

書誌詳細
主要な著者:	Kestell, P, Zhao, L, Jameson, M, Stratford, MR, Folkes, L, Baguley, B
フォーマット:	Journal article
言語:	English
出版事項:	2001

類似資料

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection.
著者:: Stratford, MR, 等
出版事項: (2011)

Rat Tumor Response to the Vascular-Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Plasma 5-Hydroxyindoleacetic Acid Levels, and Tumor Necrosis
著者:: Lesley D. McPhail, 等
出版事項: (2006-03-01)

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation.
著者:: Stratford, MR, 等
出版事項: (2012)

Serum 5-Hydroxyindoleacetic Acid and Ratio of 5-Hydroxyindoleacetic Acid to Serotonin as Metabolomics Indicators for Acute Oxidative Stress and Inflammation in Vancomycin-Associated Acute Kidney Injury
著者:: Hyun-Seung Lee, 等
出版事項: (2021-06-01)

Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma by HPLC with mass spectrometric detection.
著者:: Stratford, MR, 等
出版事項: (2012)

Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
著者:: Robert J. Griffin, 等
出版事項: (2000-01-01)

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection
著者:: Stratford, M, 等
出版事項: (2011)

5-Hydroxyindoleacetic acid as a biomarker for revealing perforation in acute appendicitis
著者:: Arash Mohammadi Tofigh, 等
出版事項: (2024-10-01)

Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid
著者:: Korrapati V. Sathyasaikumar, 等
出版事項: (2022-08-01)

Impact of plasma 5-hydroxyindoleacetic acid, a serotonin metabolite, on clinical outcome in septic shock, and its effect on vascular permeability
著者:: Takeshi Tanaka, 等
出版事項: (2021-07-01)

Autoimmune Pancreatitis Associated with High Levels of Chromogranin A, Serotonin and 5-Hydroxyindoleacetic Acid
著者:: Elisabetta Nobili, 等
出版事項: (2008-01-01)

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation
著者:: Stratford, M, 等
出版事項: (2012)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
著者:: Ilias Zampros, 等
出版事項: (2012-01-01)

Zinc-Substituted Pheophorbide A Is a Safe and Efficient Antivascular Photodynamic Agent
著者:: Milena J. Szafraniec, 等
出版事項: (2022-02-01)

Promising novel treatment against keloids: Antivascular endothelial growth factor agents
著者:: Bahareh Abtahi-Naeini, 等
出版事項: (2019-01-01)

Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity.
著者:: Hoskin, P, 等
出版事項: (2000)

Surgical Correction of Carcinoid Heart Disease Improves Liver Function and 5-Hydroxyindoleacetic Acid Levels
著者:: Husnain Abbas Shah, 等
出版事項: (2022-04-01)

Influence of plasma glutathione levels on radiation mucositis.
著者:: Wardman, P, 等
出版事項: (2001)

Bypass of Tumor Drug Resistance by Antivascular Therapy
著者:: Dina Preise, 等
出版事項: (2003-11-01)

5-Hydroxyindoleacetic acid, a new ligand for GPR35, plays an important role in inflammatory disease
著者:: Yang Zhisheng, 等
出版事項: (2022-12-01)

The correlation between urinary 5-hydroxyindoleacetic acid and sperm quality in infertile men and rotating shift workers
著者:: Pariente José A, 等
出版事項: (2010-11-01)

Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels
著者:: Christopher Adams, 等
出版事項: (2023-01-01)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
著者:: Kumar Anshuman, 等
出版事項: (2019-01-01)

Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
著者:: Xiaocong Ma, 等
出版事項: (2023-04-01)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
著者:: Ajay Indur Dudani, 等
出版事項: (2019-01-01)

Multi-omic Profiling Reveals that Intra-abdominal-Hypertension-Induced Intestinal Damage Can Be Prevented by Microbiome and Metabolic Modulations with 5-Hydroxyindoleacetic Acid as a Diagnostic Marker
著者:: Fang Li, 等
出版事項: (2022-06-01)

Increase of Urinary 5-Hydroxyindoleacetic Acid Excretion but Not Serum Chromogranin a Following Over-The-Counter 5-Hydroxytryptophan Intake
著者:: Tisha Joy, 等
出版事項: (2008-01-01)

5-Fluoroindole-3-acetic acid: a prodrug activated by a peroxidase with potential for use in targeted cancer therapy.
著者:: Folkes, L, 等
出版事項: (2002)

Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer
著者:: Chueh-Yi Huang, 等
出版事項: (2016-06-01)

Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.
著者:: Merryl R Lobo, 等
出版事項: (2015-01-01)

Assessment of Serotonin Metabolite 5-hydroxyindoleacetic Acid Levels in Urine Sample for Diagnosis and Treatment Efficacy in Children with Dysfunctional Voiding and Their Interaction with Biofeedback Therapy
著者:: Bahadır Topuz, 等
出版事項: (2018-12-01)

Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity.
著者:: Bruno B Andrade, 等
出版事項: (2010-04-01)

Acute renal failure after intravitreal antivascular endothelial growth factor therapy
著者:: Yu-Fang Huang, 等
出版事項: (2017-06-01)

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
著者:: Tranos P, 等
出版事項: (2013-06-01)

Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
著者:: Yewande Olubunmi Babalola, 等
出版事項: (2020-01-01)

Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
著者:: Yukio Sassa, 等
出版事項: (2010-04-01)

Surrogate markers in HIV disease.
著者:: Peto, T
出版事項: (1996)

Surrogates Markers of Insulin Resistance
著者:: Ekhlas Khalid Hameed, 等
出版事項: (2022-05-01)

Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings
著者:: Ashwini Shete, 等
出版事項: (2020-07-01)

Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals.
著者:: Folkes, L, 等
出版事項: (2007)